Home›US Markets›Sectors›Moderna cancer-vaccine breakthrough lifts biopharma st…

Moderna cancer-vaccine breakthrough lifts biopharma stocks broadly

The biopharmaceutical sector, which has struggled for years, has turned higher recently as investors reprice growth prospects tied to Moderna's development.

Reported · Written up by our desk · Sectors

Moderna's cancer-vaccine breakthrough is helping drive a broad rally across the biopharma sector, MarketWatch reports.

The outlet notes that the group had endured a prolonged downturn in recent years, but momentum has improved in recent sessions.

The move underscores how late-stage clinical progress and related expectations can lift sentiment across the broader segment, not just the individual company.

More like this

Sources